Serum metabolic profiling using small molecular water-soluble metabolites in individuals with schizophrenia: A longitudinal study using a pre-post-treatment design

Psychiatry and Clinical Neurosciences
Bing CaoJingyu Wang

Abstract

We sought to compare alterations in serum bioenergetic markers within a well-characterized sample of adults with schizophrenia at baseline and after 8 weeks of pharmacological treatment with the hypothesis that treatment would be associated with significant changes in bioenergetic markers given the role of bioenergetic dysfunction in schizophrenia. We recruited adults with schizophrenia (n = 122) who had not received pharmacological treatment for at least 1 month prior to enrollment, including drug-naïve (i.e., first-episode) participants and treatment non-adherent participants. Pre- and post-treatment serum samples were analyzed using liquid chromatography-tandem mass spectrometry. Metabolites with the greatest change, when comparing pre- and post-treatment levels, were identified revealing 14 water-soluble metabolites of interest. The composition of these metabolites was: amino acids (n = 6), carnitines (n = 4), polar lipids (n = 3), and organic acid (n = 1). All amino acids and lysophosphatidylcholines (LysoPC) were increased, while the four carnitines - oleoylcarnitine, L-palmitoylcarnitine, linoleyl carnitine, and L-acetylcarnitine - were decreased post-treatment. Of these metabolite biomarkers, six - oleoylcarnitine, lino...Continue Reading

References

Mar 31, 1999·Schizophrenia Bulletin·J Addington, D Addington
Jun 17, 2000·Biochimica Et Biophysica Acta·J Kerner, C Hoppel
Mar 11, 2004·European Journal of Biochemistry·Jason M GoodingE David Saggerson
Sep 15, 2004·Molecular Aspects of Medicine·Ashraf Virmani, Zbigniew Binienda
Jul 12, 2005·Schizophrenia Research·Hans-Gert BernsteinGerburg Keilhoff
Aug 5, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Wook Joon ChungHarald Sontheimer
Aug 29, 2006·PLoS Medicine·Rima Kaddurah-Daouk
Apr 4, 2007·The British Journal of Nutrition·Peng LiGuoyao Wu
Apr 19, 2007·Molecular Psychiatry·R Kaddurah-DaoukK R R Krishnan
Jul 31, 2007·FEBS Letters·Katarzyna A NałeczStanisław Grześkiewicz
Nov 22, 2007·The Journal of Clinical Endocrinology and Metabolism·Lonneke J M van NimwegenHans P Sauerwein
Apr 23, 2008·Annals of Medicine·Ling ShaoMarquis P Vawter
Aug 7, 2008·Genome Biology·Philipp KhaitovichSabine Bahn
Mar 28, 2009·Schizophrenia Bulletin·Oliver D Howes, Shitij Kapur
Jun 27, 2009·Mass Spectrometry Reviews·Simon CubbonJane Thomas-Oates
Sep 2, 2009·Progress in Lipid Research·Lauren L JonesPeggy R Borum
Jul 20, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Hua-Lin CaiHai-Sen Ye
Sep 14, 2010·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Hayley B ClayChristine Konradi
Nov 18, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Elvar M EyjolfssonUrsula Sonnewald
Sep 1, 2011·Analytical and Bioanalytical Chemistry·Bogusław Buszewski, Sylwia Noga
Oct 26, 2011·Molecular Psychiatry·J YangC Wan
Jun 2, 2012·Bioanalysis·David RojoFrancisco J Rupérez
Aug 16, 2012·Translational Psychiatry·Y HeD Rujescu
Sep 18, 2012·British Journal of Pharmacology·J E CarlandR J Vandenberg
Nov 1, 2012·Molecular & Cellular Proteomics : MCP·Peng ZhengPeng Xie
Apr 6, 2013·Medical Hypotheses·Arnold E Eggers
Feb 2, 2016·Biochimica Et Biophysica Acta·Nicola LongoMarzia Pasquali

❮ Previous
Next ❯

Citations

Jul 8, 2020·Molecular Psychiatry·Margot FournierKathryn Hess
Jul 1, 2020·International Journal of Molecular Sciences·Eva Knuplez, Gunther Marsche
Jan 31, 2020·BioMed Research International·Orwa AlbitarSiti Maisharah Sheikh Ghadzi
Aug 6, 2021·Current Pharmaceutical Design·Juan D MolinaFrancisco López-Muñoz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here